Concepedia
Statistics
Publications
5
Citations
98
H-Index
Active since
2019
Affiliations
University of California, Los Angeles(Current)
Chulabhorn Hospital
Peking University
University of California System
Peking University People's Hospital
Pichaya Thanindratarn is an author at University of California, Los Angeles specializing in oncology, medicine, and molecular oncology.
Publications per year
2019–2021
Cyclin E1 is a prognostic biomarker and potential therapeutic target in osteosarcoma
Ran Wei, Pichaya Thanindratarn, Dylan C. Dean et al. · Journal of Orthopaedic Research® · 2020 · 31 citations · Full text
Medicine, Molecular Biology, Oncology +17
Expression of Concern: T‐LAK cell‐originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcoma
Pichaya Thanindratarn, Ran Wei, Dylan C. Dean et al. · Molecular Oncology · 2021 · 19 citations · Full text
Cyclin-dependent kinase 12 (CDK12) in chordoma: prognostic and therapeutic value
Pichaya Thanindratarn, Dylan C. Dean, Wenlong Feng et al. · European Spine Journal · 2020 · 18 citations
Medicine, Cancer Biology, Oncology +14
T‐LAK cell‐originated protein kinase (TOPK) is a Novel Prognostic and Therapeutic Target in Chordoma
Pichaya Thanindratarn, Dylan C. Dean, Scott D. Nelson et al. · Cell Proliferation · 2020 · 18 citations · Full text
Medicine, Cancer Biology, Oncology +13
RETRACTED: Establishment and Characterization of a Recurrent Osteosarcoma Cell Line: OSA 1777
Pichaya Thanindratarn, Xiaoyang Li, Dylan C. Dean et al. · Journal of Orthopaedic Research® · 2019 · 12 citations · Full text
Medicine, Cell Biology, Oncology +17
1–5 of 5